Refers to a drug or therapy that uses substances that are injected into the body and travel through the bloodstream to deliver the therapy to the area of interest. The NTLA-2001 Phase 1 clinical trial is the first time a CRISPR/Cas9 gene editing treatment will be delivered through a vein of the human body to edit genes.